Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VOLITIONRX LTD Director's Dealing 2020

Apr 15, 2020

34395_dirs_2020-04-15_e8853323-c313-4c13-987b-c1e87f7ef651.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2020-04-13

Reporting Person: Futcher Edward (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-04-13 Common Stock A 11250 Acquired 38250 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 356000 Indirect

Footnotes

F1: Dr. Futcher received restricted stock units subject to a 2-year vesting schedule, vesting as to 5,625 units on each of 04/13/21 and 04/13/22, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2: These shares of Common Stock are beneficially owned by The Dill Faulkes Educational Trust Limited ("DFET"), a UK registered charity. Dr. Futcher is a director and trustee of DFET and shares voting and dispositive control over these shares. Dr. Futcher disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.